<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-2-22-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-2-3-10</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Degenerative and Metabolic Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Monoamine Metabolites in Rett Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>03</month>
<year>1988</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>08</month>
<year>2016</year>
</pub-date>
<volume>2</volume>
<issue>3</issue>
<fpage>22</fpage>
<lpage>22</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1988 The Author(s)</copyright-statement>
<copyright-year>1988</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/S0022-3476(88)80060-X" vol="112" page="234">
<article-title>Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Cerebral metabolites of noradrenaline, dopamine and serotonin, y-aminobutyric acid, and 23 amino acids were present in normal concentrations in the CSF of 5 girls with Rett syndrome studied in the Depts of Pharmacology and Therapeutics, and Dept of Paediatrics, University of British Columbia, Vancouver, Canada.</p>
</abstract>
<kwd-group>
<kwd>Cerebral Metabolites</kwd>
<kwd>Y-Aminobutyric Acid</kwd>
<kwd>Rett Syndrome</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Cerebral metabolites of noradrenaline, dopamine and serotonin, y-aminobutyric acid, and 23 amino acids were present in normal concentrations in the CSF of 5 girls with Rett syndrome studied in the Depts of Pharmacology and Therapeutics, and Dept of Paediatrics, University of British Columbia, Vancouver, Canada. The authors doubt that any biochemical abnormalities have been clearly established as characteristic of the syndrome. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p>
<bold>COMMENT</bold>. A previous report of low CSF levels of monoamine metabolites in patients with Rett syndrome [<xref ref-type="bibr" rid="CIT0002">2</xref>] is not supported by the present study. Hyperammonemia reported originally by Rett is another suggested biochemical basis for the syndrome unconfirmed in subsequent reports. The lack of uniformity of these findings suggests that Rett syndrome is a nonspecific entity with more than one etiology.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perry</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Crichton</surname>
<given-names>JU</given-names>
</name>
</person-group>
<article-title>Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome</article-title>
<source>J Pediatr</source>
<year>1988</year>
<month>Feb</month>
<volume>112</volume>
<issue>2</issue>
<fpage>234</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(88)80060-X</pub-id>
<pub-id pub-id-type="pmid">2448442</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Riccardi</surname>
<given-names>VM</given-names>
</name>
</person-group>
<article-title>Reduction of biogenic amine levels in the Rett syndrome</article-title>
<source>N Engl J Med</source>
<year>1985</year>
<month>Oct</month>
<day>10</day>
<volume>313</volume>
<issue>15</issue>
<fpage>921</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM198510103131504</pub-id>
<pub-id pub-id-type="pmid">2412119</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
